. | . |
Superior 'bio-ink' for 3D printing pioneered by Staff Writers New Brunswick NJ (SPX) Feb 11, 2020
Rutgers biomedical engineers have developed a "bio-ink" for 3D printed materials that could serve as scaffolds for growing human tissues to repair or replace damaged ones in the body. The study was published in the journal Biointerphases. Bioengineered tissues show promise in regenerative, precision and personalized medicine; product development; and basic research, especially with the advent of 3D printing of biomaterials that could serve as scaffolds, or temporary structures to grow tissues. Hyaluronic acid, a natural molecule found in many tissues throughout the body, has many properties ideal for creating customized scaffolds, but lacks the durability required. The Rutgers engineers use modified versions of hyaluronic acid and polyethylene glycol to form a gel that is strengthened via chemical reactions and would serve as a scaffold. "Instead of an ink color for an inkjet printer, we want the mixture to have properties that are right for specific cells to multiply, differentiate and remodel the scaffold into the appropriate tissue," said senior author David I. Shreiber, a professor who chairs the Department of Biomedical Engineering in the School of Engineering at Rutgers University-New Brunswick. "We focus on the stiffness of the gel and scaffold binding sites that cells can latch onto." Groups of cells in the body generally make their own support structures, or scaffolds, but scientists can build them from proteins, plastics and other sources, according to the National Institutes of Health. Shreiber and lead author Madison D. Godesky, who earned a doctorate at Rutgers, envisioned a system where hyaluronic acid and polyethylene glycol serve as the basic "ink cartridges" for 3D printing. The system would also have other ink cartridges featuring different cells and ligands, which serve as binding sites for cells. The system would print gel scaffolds with the right stiffness, cells and ligands, based on the type of tissue desired. "Both the stiffness and the binding sites provide important signals to cells," Godesky said. "What especially distinguishes our work from previous studies is the potential to control the stiffness and ligands independently through combinations of inks."
Iron nanorobots show their true mettle Thuwal, Saudi Arabia (SPX) Jan 29, 2020 Drug-coated iron nanowires that can be guided to the site of a tumor using an external magnetic field before activating a three-step cancer-killing mechanism could provide an effective option for cancer therapy. Co-developed by KAUST researchers, these nanowires release their drug cargo inside cancer cells, while also punching holes in the cell's membrane and delivering a blast of heat. While the combination therapy maximizes cancer cell death, its highly targeted nature should minimize side effec ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |